Martin E Dowty

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Clinical pharmacology and therapeutics

Pharmacology research & perspectives

Pfizer Global Research and Development

University of Wisconsin (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Global Research and Development

United States

Associate Research Fellow :: Pharmacokinetics Dynamics and Metabolism

Education History

University of Wisconsin

United States

PHD :: School of Pharmacy

Publications

Martin E Dowty, Ruolun Qiu, Alyssa Dantonio, Mark Niosi, Angela Doran, Amanda Balesano, Stephen W Wright, Gregory S Walker, Raman Sharma
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite. Drug metabolism and disposition: the biological fate of chemicals 52 (7) (2024)
Jonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S Purohit, Martin E Dowty
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug metabolism and disposition: the biological fate of chemicals (2024)
Martin E Dowty, Ruolun Qiu, Alyssa Dantonio, Mark Niosi, Angela Doran, Amanda Balesano, Stephen W Wright, Gregory S Walker, Raman Sharma
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite . Drug metabolism and disposition: the biological fate of chemicals (2024)
Martin E Dowty, Ruolun Qiu, Alyssa Dantonio, Mark Niosi, Angela Doran, Amanda Balesano, Stephen W Wright, Gregory S Walker, Raman Sharma
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite. Drug metabolism and disposition: the biological fate of chemicals 52 (7) (2024)
Vivek Purohit, Kazuko Sagawa, Hao-Jui Hsu, Joseph Kushner, Martin E Dowty, Susanna Tse, Jian Lin, Andrew Blanchard, Arnab Mukherjee, Vu Le, Cheng Chang
Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage Form. Clinical pharmacology and therapeutics (2024)
Jonathan N Bauman, Angela C Doran, Amanda King-Ahmad, Raman Sharma, Gregory S Walker, Jian Lin, Tsung H Lin, Jean-Baptiste Telliez, Sakambari Tripathy, Theunis C Goosen, Christopher Banfield, Bimal K Malhotra, Martin E Dowty
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans. Drug metabolism and disposition: the biological fate of chemicals 50 (8) (2022)
Martin E Dowty, Tsung H Lin, Michael I Jesson, Martin Hegen, David A Martin, Vaibhav Katkade, Sujatha Menon, Jean-Baptiste Telliez
Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition. Pharmacology research & perspectives 7 (6) (2019)

Martin E Dowty.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin E Dowty